BIOSPECIFICS
TECHNOLOGIES CORP.
|
(Exact
name of registrant as specified in its
charter)
|
Delaware
|
0-19879
|
11-3054851
|
(State
or Other Jurisdiction
of
Incorporation)
|
(Commission
File Number)
|
(IRS
Employer
Identification
No.)
|
|
·
|
the
acquisition by any “person” (as such term is defined in Section 3(a)(9) of
the Securities Exchange Act of 1934), other than the Company or
its
affiliates, from any party of an amount of the capital stock of
the
Company, so that such person holds or controls 40% or more of the
Company’s capital stock; or
|
|
·
|
a
merger or similar combination between the Company and another entity
after
which 40% or more of the voting stock of the surviving corporation
is held
by persons other than the Company or its affiliates;
or
|
|
·
|
a
merger or similar combination (other than with the Company) in
which the
Company is not the surviving corporation;
or
|
|
·
|
the
sale of all or substantially all of the Company’s assets or
business.
|
|
·
|
assignment
to Mr. Wegman of any duties inconsistent in any material respect
with the
his position (including titles and reporting requirements), authority,
duties or responsibilities as contemplated by the job description
of his
position, or any other action by the Company or its successor,
which
results in a diminution in such position, authority, duties or
responsibilities, other than an isolated, insubstantial and inadvertent
action not taken in bad faith and which is remedied by the Company
promptly after receipt of written notice thereof given by Mr.
Wegman;
|
|
·
|
a
reduction in Mr. Wegman’s annual base salary (or an adverse change in the
form or timing of the payment thereof), other than an isolated,
insubstantial and inadvertent action not taken in bad faith and
which is
remedied by the Company promptly after receipt of written notice
thereof
given by Mr. Wegman; or the elimination of or reduction of any
benefit
under any bonus, incentive or other employee benefit plan in effect
on the
day immediately preceding the Change in Control, without an economically
equivalent replacement, if Mr. Wegman was a participant or member
of such
plan on the day immediately preceding the Change in
Control;
|
|
·
|
the
Company’s or its successor’s requiring Mr. Wegman (i) to be based at any
office or location more than 25 miles away from the office or location
where he was performing services immediately prior to the Change
in
Control, or (ii) to relocate his or her personal residence, or
(iii) the
Company’s requiring Mr. Wegman to travel on Company business to a
substantially greater extent than required immediately prior to
the Change
in Control.
|
|
(d)
|
Exhibits
|
|
10.1
|
Form
of Director Change of Control
Agreement
|
|
10.2
|
Wegman
Change of Control Agreement, between Thomas L. Wegman and BioSpecifics
Technologies Corp., dated June 18,
2007
|
Date:
June 22, 2007
|
|
BIOSPECIFICS
TECHNOLOGIES CORP.
——————————————————
(Registrant)
/s/
Thomas L. Wegman
|
|
——————————————————
Thomas
L. Wegman
President
|